论文部分内容阅读
目的 评价甘氨双唑钠 (CM)在中、晚期恶性肿瘤介入治疗中的临床应用价值。方法 以病人自身对照 ,观察单纯介入治疗和介入治疗加甘氨双唑钠两种方案的临床疗效。结果 5 0例中 ,3 8例 (76.0 % )病情得到明显控制 ,病灶缩小。结论 该药能提高肿瘤乏氧细胞对化疗药物的敏感性 ,从而提高疗效 ,减轻毒副作用
Objective To evaluate the clinical value of glycididazole sodium (CM) in interventional therapy of middle and advanced malignant tumors. Methods The patient’s own control, the observation of simple interventional therapy and interventional therapy plus glycopyrroxol sodium two programs clinical curative effect. Results Fifty-eight cases (76.0%) of the 50 cases were significantly controlled and the lesion size was reduced. Conclusion The drug can increase the sensitivity of tumor hypoxia cells to chemotherapeutic drugs to improve the curative effect and reduce the side effects